Douglas Schirle
Analyst · Tristan Gerra
Thank you, Lee-Lean. We reported net income of $920,000 or $0.03 per diluted share on net revenues of $16.8 million for our first fiscal quarter ended June 30, 2012, compared to net income of $3.3 million or $0.11 per diluted share on net revenues of $23 million from the comparable period a year ago.
In the prior quarter ended March 31, 2012, we had $829,000 or $0.03 per diluted share and net revenues of $18.7 million. Total operating expenses were $5.9 million compared to $8.7 million from the prior quarter and $6 million in the first quarter of fiscal 2012. First quarter 2013 research and development expense was $2.8 million compared to $2.7 million from the prior quarter and $2.6 million a year ago.
First quarter selling, general and administrative expense of $3 million included $455,000 in litigation-related expenses compared to SG&A of $6.1 million in the prior quarter, when litigation related expenses of $3.7 million comprised more than half of SG&A.
A year ago, SG&A of $3.4 million included $782,000 in litigation-related expenses. As it has previously been explained at considerable length by us, this litigation-related expenses are primarily associated with the patent infringement proceeding pending before the United States International Trade Commission, which was instituted in response to a complaint filed by Cypress Semiconductor Corp. in June 2011 and the related antitrust lawsuit filed by GSI against Cypress in July of 2011.
First quarter direct and indirect sales to Cisco Systems were $4.1 million or 24.2% of net revenues compared to $6 million or 32.1% of net revenues in the prior quarter and $9.6 million or 41.6% of net revenues in the same period a year ago. Sales to Huawei Technologies, our second largest customer, were $1.3 million or 74.5% of net revenues in the first quarter compared to $1.4 million or 7.2% of net revenues in the prior quarter and $1.4 million or 6% of net revenues a year ago.
Military/defense sales were 11.9% of shipments compared to 11.1% of shipments in the prior quarter and 8.9% of shipments in the comparable period a year ago. SigmaQuad sales were 38% of shipments compared to 38.3% in the prior quarter and 32.5% in the first quarter of fiscal 2012.
Total first quarter pretax stock-based compensation expense was $562,000 compared to $539,000 in the prior quarter and $511,000 from the comparable quarter a year ago. At June 30, 2012, we had $59.2 million in cash, cash equivalents and short-term investments, $30.4 million of long-term investments, $86.2 million in working capital, no debt and stockholders' equity of $128.6 million.
Accounts payable at June 30 is $4 million, down from $5.5 million at March 31, 2012. Net inventory was $17.1 million at June 30, slightly up from $16.7 million at March 31. Inventory turns at June 30, 2012 are 2.3x compared to 2.4 at March 31, 2012.
Depreciation and amortization expense was $638,000 for the quarter. Under our expanded repurchase program, we are authorized to repurchase up to a total of $20 million of our common stock from time to time from the open market or private transactions. Specific timing and amount of the repurchases will be dependent on market conditions, securities law limitations and other factors. The repurchase program may be suspended or terminated at any time without prior notice.
During the quarter ended June 30, 2012, we repurchased 427,500 shares at an average cost of $4.25 per share. To date, we have repurchased a total of 3,247,560 shares at an average cost of $3.39 per share for a total cost of $12.3 million.
We currently expect net revenues in the second quarter of fiscal 2013 to be in the range of $16 million to $18 million with gross margin or approximately 41%. Net revenues in the June quarter continued to be negatively affected by uncertainty regarding our pending patent litigation with Cypress. We believe that this uncertainty will continue to extract our revenues and will likely have a continued impact in the second quarter.
We also expect that ongoing legal expenses, related patent litigation and antitrust litigation will continue to affect our operating income and our bottom line. These expenses are expected to be approximately $500,000 in the second quarter. Operating expenses in total are expected to be similar to the first quarter of 2013.
Operator, at this time, we will open the call to Q&A.